Stay updated on GEMINI 1 Tolebrutinib Clinical Trial
Sign up to get notified when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.

Latest updates to the GEMINI 1 Tolebrutinib Clinical Trial page
- ChecktodayChange DetectedThe page revision was updated from v3.6.0 to v3.6.3, indicating a newer version of the document. This update reflects a version-control change rather than a substantive modification to study details.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdds a recruitment-status note that the study is no longer enrolling and introduces new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment header formatting and the revision tag.SummaryDifference0.2%

- Check21 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, signaling a software revision on the page. The update does not alter study details or visible content.SummaryDifference0.0%

- Check43 days agoChange DetectedAn updated revision tag from v3.5.3 to v3.5.4 is shown, indicating a minor build/metadata update. There are no changes to the study details or user-facing content.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check101 days agoChange DetectedNapoli, Italy, 80131 was removed and Naples, Italy, 80131 was added in the locations list. The page revision label was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to GEMINI 1 Tolebrutinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 1 Tolebrutinib Clinical Trial page.